Patents by Inventor Claus Fuglsang

Claus Fuglsang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for producing a soy protein product
    Publication number: 20070031577
    Abstract: The present invention relates to a method for producing a soy protein product by treatment of soy protein with at least one oxidoreductase.
    Type: Application
    Filed: July 17, 2006
    Publication date: February 8, 2007
    Applicants: Novozymes A/S, Solae, LLC.
    Inventors: Gitte Budolfsen, Claus Fuglsang, Theodore Wong, Phillip Kerr
  • Thermostable enzyme compositions
    Publication number: 20060193843
    Abstract: The present invention relates to a composition comprising at least two thermostable enzymes selected from the group consisting of endoglucanase, xylanase, phytase, protease, galactanase, mannanase, dextranase, and alpha-galactosidase. The thermostable enzymes have a melting temperature, Tm, of at least 70° C. Preferred compositions comprise a xylanase of glycoside hydrolase family 11, and an endoglucanase which is homologous to a thermostable glycoside hydrolase family 5 endoglucanase derived from Thermoascus aurantiacus. Preferred xylanases are derived from Aspergillus, Bacillus, Humicola, Thermomyces and Trichoderma. The composition is particularly useful for animal feed purposes. Optional additional components are vitamins, minerals, and anti-microbial peptides.
    Type: Application
    Filed: January 23, 2003
    Publication date: August 31, 2006
    Applicant: DSM IP ASSETS B.V.
    Inventors: Wenping Wu, Dan Pettersson, Claus Fuglsang
  • Alpha-amylase mutants with altered properties
    Publication number: 20050250663
    Abstract: The present invention relates to variants (mutants) of parent Termamyl-like alpha-amylases, which variant has alpha-amylase activity and exhibits altered stability, in particular at high temperatures and/or at low pH relative, and/or low Ca2+ to the parent alpha-amylase.
    Type: Application
    Filed: July 29, 2003
    Publication date: November 10, 2005
    Applicant: Novozymes A/S
    Inventors: Thomas Thisted, Soren Kjaerulff, Carsten Andersen, Claus Fuglsang
  • Lipolytic enzyme variants
    Publication number: 20050059130
    Abstract: The substrate specificity of a lipolytic enzyme can be modified by making alterations to the amino acid sequence in a defined region of the lipolytic enzyme, so as to increase the level of a desired activity or to decrease the level of an undesired activity. Thus, the inventors have developed lipolytic enzyme variants with a modified amino acid sequence with a substrate specificity which can be tailored for specific uses.
    Type: Application
    Filed: November 22, 2004
    Publication date: March 17, 2005
    Applicant: Novozymes A/S
    Inventors: Kirsten Bojsen, Allan Svendsen, Claus Fuglsang, Shamkant Patkar, Kim Borch, Jesper Vind, Andreas Petri, Sanne Schroder Glad, Gitte Budolfsen
  • Haloperoxidases from Curvularia verruculosa and nucleic acids encoding same
    Patent number: 5965418
    Abstract: The present invention relates to Curvularia verruculosa haloperoxidases and isolated nucleic acid fragments comprising nucleic acid sequences encoding the haloperoxidases as well as nucleic acid constructs, vectors, and recombinant host cells comprising the nucleic acid sequences. The invention also relates to methods for recombinant production of the haloperoxidase. The invention further relates to compositions comprising the haloperoxidases and methods of using the compositions for killing microbial cells or inhibiting growth of microbial cells.
    Type: Grant
    Filed: April 16, 1997
    Date of Patent: October 12, 1999
    Assignees: Novo Nordisk A/S, Novo Nordisk Biotech, Inc.
    Inventors: Claus Fuglsang, Karen Oxenb.o slashed.ll, Torben Halkier, Randy M. Berka, Joel Cherry
  • Haloperoxidases from curvularia verruculosa and nucleic acids encoding same
    Patent number: 5866393
    Abstract: The present invention relates to Curvularia verruculosa haloperoxidases and isolated nucleic acid fragments comprising nucleic acid sequences encoding the haloperoxidases as well as nucleic acid constructs, vectors, and recombinant host cells comprising the nucleic acid sequences. The invention also relates to methods for recombinant production of the haloperoxidase. The invention further relates to compositions comprising the haloperoxidases and methods of using the compositions for killing microbial cells or inhibiting growth of microbial cells.
    Type: Grant
    Filed: July 9, 1996
    Date of Patent: February 2, 1999
    Assignees: Novo Nordisk A/S, Novo Nordisk BioTech, Inc.
    Inventors: Claus Fuglsang, Karen Oxenb.o slashed.ll, Torben Halkier, Randy M. Berka, Joel Cherry
  • Metalloprotease having increased activity
    Patent number: 5843753
    Abstract: The present invention relates to a novel metalloprotease obtainable from a fungus having increased proteolytic activity. Additionally, the invention related to isolated nucleic acid fragments encoding said metalloprotease as well as vectors, DNA constructs, and recombinant host cells comprising said nucleic acid fragments.
    Type: Grant
    Filed: March 3, 1995
    Date of Patent: December 1, 1998
    Assignees: Novo Nordisk A/S, Novo Nordisk Biotech, Inc.
    Inventors: Jeffrey R. Shuster, Mark Madden, Donna L. Moyer, Claus Fuglsang, Sven Branner
  • Metalloprotease having increased activity
    Patent number: 5807729
    Abstract: The present invention relates to a novel metalloprotease obtainable from a fungus having increased proteolytic activity. Additionally, the invention related to isolated nucleic acid fragments encoding said metalloprotease as well as vectors, DNA constructs, and recombinant host cells comprising said nucleic acid fragments.
    Type: Grant
    Filed: May 17, 1995
    Date of Patent: September 15, 1998
    Assignees: Novo Nordisk A/S, Novo Nordisk Biotech, Inc.
    Inventors: Jeffrey R. Shuster, Mark Madden, Donna L. Moyer, Claus Fuglsang, Sven Branner
  • Processes for producing an enzyme
    Patent number: 5702934
    Abstract: The present invention is related to a process for producing an active enzyme comprising fermenting the proform of the active enzyme in the present of a proteolytic enzyme different from the active enzyme and capable of converting the proenzyme into an active enzyme as well as to host cells, recombinant expression vectors and host cells suitable for use in the process.
    Type: Grant
    Filed: May 4, 1994
    Date of Patent: December 30, 1997
    Assignees: Novo Nordisk A/S, Novo Nordisk Biotech, Inc.
    Inventors: Sven Hastrup, Sven Branner, Birthe Ravn J.o slashed.rgensen, Tove Christensen, Birgitte Bojer J.o slashed.rgensen, Jeffrey R. Shuster, Mark Madden, Donna L. Moyer, Claus Fuglsang
  • Metalloprotease having increased activity
    Patent number: 5691162
    Abstract: The present invention relates to a novel metalloprotease obtainable from a fungus having increased proteolytic activity. Additionally, the invention related to isolated nucleic acid fragments encoding said metalloprotease as well as vectors, DNA constructs, and recombinant host cells comprising said nucleic acid fragments.
    Type: Grant
    Filed: May 17, 1995
    Date of Patent: November 25, 1997
    Assignees: Novo Nordisk A/S, Novo Nordisk Biotech, Inc.
    Inventors: Jeffrey R. Shuster, Mark Madden, Donna L. Moyer, Claus Fuglsang, Sven Branner